- Home
- NSTS vs NOTV Comparison
NSTS vs NOTV Comparison
Compare NSTS & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSTS
- NOTV
- Stock Information
- Founded
- NSTS 1921
- NOTV 1974
- Country
- NSTS United States
- NOTV United States
- Employees
- NSTS N/A
- NOTV N/A
- Industry
- NSTS Savings Institutions
- NOTV Biotechnology: Pharmaceutical Preparations
- Sector
- NSTS Finance
- NOTV Health Care
- Exchange
- NSTS Nasdaq
- NOTV Nasdaq
- Market Cap
- NSTS 64.0M
- NOTV 72.1M
- IPO Year
- NSTS N/A
- NOTV 1997
- Fundamental
- Price
- NSTS $11.94
- NOTV $1.89
- Analyst Decision
- NSTS
- NOTV Strong Buy
- Analyst Count
- NSTS 0
- NOTV 1
- Target Price
- NSTS N/A
- NOTV $5.00
- AVG Volume (30 Days)
- NSTS 1.6K
- NOTV 501.3K
- Earning Date
- NSTS 08-14-2025
- NOTV 08-06-2025
- Dividend Yield
- NSTS N/A
- NOTV N/A
- EPS Growth
- NSTS N/A
- NOTV N/A
- EPS
- NSTS N/A
- NOTV N/A
- Revenue
- NSTS $9,435,000.00
- NOTV $505,299,000.00
- Revenue This Year
- NSTS N/A
- NOTV $4.99
- Revenue Next Year
- NSTS N/A
- NOTV $5.39
- P/E Ratio
- NSTS N/A
- NOTV N/A
- Revenue Growth
- NSTS 69.39
- NOTV 0.85
- 52 Week Low
- NSTS $9.37
- NOTV $1.15
- 52 Week High
- NSTS $13.32
- NOTV $6.48
- Technical
- Relative Strength Index (RSI)
- NSTS 40.59
- NOTV 45.54
- Support Level
- NSTS $12.05
- NOTV $1.79
- Resistance Level
- NSTS $12.17
- NOTV $2.13
- Average True Range (ATR)
- NSTS 0.07
- NOTV 0.19
- MACD
- NSTS -0.01
- NOTV -0.01
- Stochastic Oscillator
- NSTS 0.00
- NOTV 20.00
About NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.